Drug Profile
FK 011
Latest Information Update: 02 Oct 2001
Price :
$50
*
At a glance
- Originator Fujisawa
- Class Antiasthmatics
- Mechanism of Action Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 02 Oct 2001 No-Development-Reported for Asthma in Japan (Unknown route)
- 16 Sep 1998 New profile
- 16 Sep 1998 Phase-II clinical trials for Asthma in Japan (Unknown route)